Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care, Treatment
Active
18 and over
Other
001-0015-211
NCT00127387
2.
Etanercept Mouthwash to Treat Stomatitis and Oral Pain in Patients Receiving Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
16 and over
NINR
020133
02-NR-0133, NCT00031551
Last Modified:
8/27/2008
 
First Published:
3/24/2006
3.
Phase II Study of Etanercept in Pediatric Patients With Acute Noninfectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) After Undergoing Allogeneic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
1 to 17
NCI
COG-ASCT0521
COG-PBMTC-SUP051, ASCT0521, NCT00309907
4.
Treatment for Acute Graft-Versus-Host Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
10 and over
NCI, NHLBI
285
BMT CTN 0302, U01 HL069294-05, NCT00224874
5.
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
0 to 18
Other
2004-0215
NCT00509600
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute